John Mondick currently serves as Vice President and Head of Clinical and Quantitative Pharmacology at Incyte, a role held since June 2024. Prior to this position, John was the Chief Pharmacometrics Officer at A2-Ai from February 2023 to May 2024. John's extensive experience includes serving as Vice President of PKPD, Quantitative Sciences, and holding various roles at Metrum Research Group from May 2008 to December 2022. Additionally, John worked as an Assistant Professor of Pediatrics at The Children's Hospital of Philadelphia from 2006 to 2008. Earlier career roles include Associate Scientist at DuPont Pharmaceuticals and Senior Analyst at West Pharmaceutical Services. John earned a PhD in Pharmaceutical Sciences from the University of Maryland Baltimore and a BS in Biochemistry from the University of Delaware.
This person is not in any teams
This person is not in any offices